ISPOR 21ST ANNUAL INTERNATIONAL MEETING WORKSHOP EXAMINES METHODOLOGIES FOR EVALUATING GEOSPATIAL ACCESS

Published May 25, 2016
Washington, DC—May 25, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Workshop 23—Methodologies for Evaluating Geospatial Access in Medication Use Studies—was held this afternoon in Washington, DC, USA. The discussion leaders for the session included:
  • Rajesh Balkrishnan, PhD, Professor, Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA
  • Xi Tan, PhD, PharmD, Assistant Professor, Department of Pharmaceutical Systems and Policy, West Virginia University, School of Pharmacy, Morgantown, WV, USA
  • Joseph Donohoe, PhD, Informatics and Special Projects Lead, Mountain-Pacific Quality Health, Helena, Helena, MT, USA
Large database studies that analyze health outcomes for medications often find significant variation in utilization due to differential geographical access. Discussion leaders reviewed newer measures and techniques of geospatial access to medications, including two-step floating catchment area (2SFCA), geographic hot spot analyses, and geographic weighted regression in evaluating the access and utilization of adjuvant endocrine therapy in breast cancer survivors residing in Appalachia, a poor and underserved region in the US with significant geospatial access issues. Presentations and slide decks from the ISPOR 21st Annual International meeting can be found here. Interested parties can follow news and developments from the meeting on social media using the hashtag #ISPORDC.

###

Related Stories

Promoting Fairness in Funding Decisions

Jun 24, 2026

Value in Health announced the publication of a special themed section of research papers that offer new tools to help health policy makers weigh fairness alongside cost-effectiveness when deciding which treatments and programs to fund.

Listening to Patients in the Real World

Jun 23, 2026

Value in Health, the official journal of ISPOR announced today the publication of an ISPOR Good Practices Report outlining 9 areas to strengthen the robustness, transparency, and feasibility of real-world patient-reported outcomes studies.

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×